retatrutide triple agonist obesity phase 2 trial Number 1 Top Cardiometabolic Story of 2023: with #retatrutide, a GIP-GLP-1-GCG receptor agonist, resulted in a mean weight reduction of 24.2% after 48 weeks. https://t.co/aED6xEFDI3 retatrutide triple agonist glp-1 gip

10.1038/s41598-017-18259-0 47

A bathroom counter drawer or a small organizer box in the kitchen works

revealed that the inhibition of PTEN via the activation of the PI3K/AKT pathway attenuated endoplasmic reticulum stress and apoptosis in APP/PS1 transgenic AD model mice [16]

General skincare measures can help support skin barrier function and reduce sensitivity: Moisturise regularly using fragrance-free, hypoallergenic emollients to maintain skin hydration, particularly if dryness accompanies weight loss Avoid harsh skincare products containing alcohol, strong fragrances, or exfoliating acids, which may exacerbate sensitivity Use broad-spectrum SPF 30+ sunscreen daily as a general skin protection measure, and limit prolonged sun exposure Wear loose, breathable clothing to minimise friction against sensitive skin areas Apply a cool compress to injection site reactions to help reduce localised redness or discomfort Maintain a balanced diet in line with the NHS Eatwell Guide